Financhill
Buy
58

OGI.TO Quote, Financials, Valuation and Earnings

Last price:
$2.46
Seasonality move :
9.44%
Day range:
$2.44 - $2.71
52-week range:
$1.22 - $2.89
Dividend yield:
0%
P/E ratio:
138.95x
P/S ratio:
1.44x
P/B ratio:
0.92x
Volume:
1.4M
Avg. volume:
217.9K
1-year change:
22.79%
Market cap:
$353.8M
Revenue:
$159.8M
EPS (TTM):
$0.03

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
OGI.TO
Organigram Global, Inc.
$73M -$0.01 63.13% -80% $3.00
ACB.TO
Aurora Cannabis, Inc.
$86.5M -$0.03 4.79% -91.67% $7.80
CRON.TO
Cronos Group, Inc.
$51.3M -$0.07 33.92% -156.68% $3.95
TSND.TO
Terrascend Corp.
$92M -$0.03 -12.43% -74.49% $1.74
WEED.TO
Canopy Growth Corp.
$71.8M -$0.11 -5.09% -95.48% $3.25
XLY.TO
Auxly Cannabis Group, Inc.
-- -- -- -- $0.2500
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
OGI.TO
Organigram Global, Inc.
$2.64 $3.00 $353.8M 138.95x $0.00 0% 1.44x
ACB.TO
Aurora Cannabis, Inc.
$7.03 $7.80 $397.7M 116.20x $0.00 0% 1.07x
CRON.TO
Cronos Group, Inc.
$4.49 $3.95 $1.7B 34.17x $0.00 0% 9.34x
TSND.TO
Terrascend Corp.
$1.27 $1.74 $388M -- $0.00 0% 0.98x
WEED.TO
Canopy Growth Corp.
$2.40 $3.25 $821.3M -- $0.00 0% 1.57x
XLY.TO
Auxly Cannabis Group, Inc.
$0.1550 $0.2500 $209M 5.08x $0.00 0% 1.55x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
OGI.TO
Organigram Global, Inc.
2.32% 2.654 3.71% 1.37x
ACB.TO
Aurora Cannabis, Inc.
15.87% 1.055 19.86% 1.52x
CRON.TO
Cronos Group, Inc.
0.16% 1.773 0.16% 20.73x
TSND.TO
Terrascend Corp.
73.06% 5.012 98.87% 0.71x
WEED.TO
Canopy Growth Corp.
26.05% 4.059 38.43% 4.06x
XLY.TO
Auxly Cannabis Group, Inc.
27.67% -1.082 33.75% 1.03x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
OGI.TO
Organigram Global, Inc.
$5.7M -$20.3M 2.24% 2.28% -28.66% $5.2M
ACB.TO
Aurora Cannabis, Inc.
-$8M -$56M -9.13% -10.69% -61.96% -$46.7M
CRON.TO
Cronos Group, Inc.
$24.8M -$6.9M 3.71% 3.71% -13.83% $12.4M
TSND.TO
Terrascend Corp.
$44.7M $15.3M -14.74% -38.6% 17.11% $620.3K
WEED.TO
Canopy Growth Corp.
$16.9M -$16.4M -39.84% -68.7% -24.59% -$19.4M
XLY.TO
Auxly Cannabis Group, Inc.
$8.8M -$4.1M 22.71% 34.07% -10.27% $8.3M

Organigram Global, Inc. vs. Competitors

  • Which has Higher Returns OGI.TO or ACB.TO?

    Aurora Cannabis, Inc. has a net margin of -8.89% compared to Organigram Global, Inc.'s net margin of -58.83%. Organigram Global, Inc.'s return on equity of 2.28% beat Aurora Cannabis, Inc.'s return on equity of -10.69%.

    Company Gross Margin Earnings Per Share Invested Capital
    OGI.TO
    Organigram Global, Inc.
    8.07% -$0.05 $394.6M
    ACB.TO
    Aurora Cannabis, Inc.
    -8.86% -$0.91 $667.4M
  • What do Analysts Say About OGI.TO or ACB.TO?

    Organigram Global, Inc. has a consensus price target of $3.00, signalling upside risk potential of 13.64%. On the other hand Aurora Cannabis, Inc. has an analysts' consensus of $7.80 which suggests that it could grow by 10.95%. Given that Organigram Global, Inc. has higher upside potential than Aurora Cannabis, Inc., analysts believe Organigram Global, Inc. is more attractive than Aurora Cannabis, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OGI.TO
    Organigram Global, Inc.
    3 1 0
    ACB.TO
    Aurora Cannabis, Inc.
    2 2 0
  • Is OGI.TO or ACB.TO More Risky?

    Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Aurora Cannabis, Inc. has a beta of 1.098, suggesting its more volatile than the S&P 500 by 9.781%.

  • Which is a Better Dividend Stock OGI.TO or ACB.TO?

    Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aurora Cannabis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Aurora Cannabis, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OGI.TO or ACB.TO?

    Organigram Global, Inc. quarterly revenues are $70.8M, which are smaller than Aurora Cannabis, Inc. quarterly revenues of $90.4M. Organigram Global, Inc.'s net income of -$6.3M is higher than Aurora Cannabis, Inc.'s net income of -$53.2M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 138.95x while Aurora Cannabis, Inc.'s PE ratio is 116.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.44x versus 1.07x for Aurora Cannabis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OGI.TO
    Organigram Global, Inc.
    1.44x 138.95x $70.8M -$6.3M
    ACB.TO
    Aurora Cannabis, Inc.
    1.07x 116.20x $90.4M -$53.2M
  • Which has Higher Returns OGI.TO or CRON.TO?

    Cronos Group, Inc. has a net margin of -8.89% compared to Organigram Global, Inc.'s net margin of 77.94%. Organigram Global, Inc.'s return on equity of 2.28% beat Cronos Group, Inc.'s return on equity of 3.71%.

    Company Gross Margin Earnings Per Share Invested Capital
    OGI.TO
    Organigram Global, Inc.
    8.07% -$0.05 $394.6M
    CRON.TO
    Cronos Group, Inc.
    49.47% $0.09 $1.6B
  • What do Analysts Say About OGI.TO or CRON.TO?

    Organigram Global, Inc. has a consensus price target of $3.00, signalling upside risk potential of 13.64%. On the other hand Cronos Group, Inc. has an analysts' consensus of $3.95 which suggests that it could fall by -12.03%. Given that Organigram Global, Inc. has higher upside potential than Cronos Group, Inc., analysts believe Organigram Global, Inc. is more attractive than Cronos Group, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OGI.TO
    Organigram Global, Inc.
    3 1 0
    CRON.TO
    Cronos Group, Inc.
    1 1 0
  • Is OGI.TO or CRON.TO More Risky?

    Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Cronos Group, Inc. has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.958%.

  • Which is a Better Dividend Stock OGI.TO or CRON.TO?

    Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cronos Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Cronos Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OGI.TO or CRON.TO?

    Organigram Global, Inc. quarterly revenues are $70.8M, which are larger than Cronos Group, Inc. quarterly revenues of $50.1M. Organigram Global, Inc.'s net income of -$6.3M is lower than Cronos Group, Inc.'s net income of $39M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 138.95x while Cronos Group, Inc.'s PE ratio is 34.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.44x versus 9.34x for Cronos Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OGI.TO
    Organigram Global, Inc.
    1.44x 138.95x $70.8M -$6.3M
    CRON.TO
    Cronos Group, Inc.
    9.34x 34.17x $50.1M $39M
  • Which has Higher Returns OGI.TO or TSND.TO?

    Terrascend Corp. has a net margin of -8.89% compared to Organigram Global, Inc.'s net margin of -15.22%. Organigram Global, Inc.'s return on equity of 2.28% beat Terrascend Corp.'s return on equity of -38.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    OGI.TO
    Organigram Global, Inc.
    8.07% -$0.05 $394.6M
    TSND.TO
    Terrascend Corp.
    49.87% -$0.12 $487.1M
  • What do Analysts Say About OGI.TO or TSND.TO?

    Organigram Global, Inc. has a consensus price target of $3.00, signalling upside risk potential of 13.64%. On the other hand Terrascend Corp. has an analysts' consensus of $1.74 which suggests that it could grow by 36.84%. Given that Terrascend Corp. has higher upside potential than Organigram Global, Inc., analysts believe Terrascend Corp. is more attractive than Organigram Global, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OGI.TO
    Organigram Global, Inc.
    3 1 0
    TSND.TO
    Terrascend Corp.
    4 0 0
  • Is OGI.TO or TSND.TO More Risky?

    Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Terrascend Corp. has a beta of 1.913, suggesting its more volatile than the S&P 500 by 91.314%.

  • Which is a Better Dividend Stock OGI.TO or TSND.TO?

    Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Terrascend Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Terrascend Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OGI.TO or TSND.TO?

    Organigram Global, Inc. quarterly revenues are $70.8M, which are smaller than Terrascend Corp. quarterly revenues of $89.7M. Organigram Global, Inc.'s net income of -$6.3M is higher than Terrascend Corp.'s net income of -$13.6M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 138.95x while Terrascend Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.44x versus 0.98x for Terrascend Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OGI.TO
    Organigram Global, Inc.
    1.44x 138.95x $70.8M -$6.3M
    TSND.TO
    Terrascend Corp.
    0.98x -- $89.7M -$13.6M
  • Which has Higher Returns OGI.TO or WEED.TO?

    Canopy Growth Corp. has a net margin of -8.89% compared to Organigram Global, Inc.'s net margin of -2.46%. Organigram Global, Inc.'s return on equity of 2.28% beat Canopy Growth Corp.'s return on equity of -68.7%.

    Company Gross Margin Earnings Per Share Invested Capital
    OGI.TO
    Organigram Global, Inc.
    8.07% -$0.05 $394.6M
    WEED.TO
    Canopy Growth Corp.
    25.3% -$0.01 $995.3M
  • What do Analysts Say About OGI.TO or WEED.TO?

    Organigram Global, Inc. has a consensus price target of $3.00, signalling upside risk potential of 13.64%. On the other hand Canopy Growth Corp. has an analysts' consensus of $3.25 which suggests that it could grow by 35.42%. Given that Canopy Growth Corp. has higher upside potential than Organigram Global, Inc., analysts believe Canopy Growth Corp. is more attractive than Organigram Global, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OGI.TO
    Organigram Global, Inc.
    3 1 0
    WEED.TO
    Canopy Growth Corp.
    1 3 1
  • Is OGI.TO or WEED.TO More Risky?

    Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Canopy Growth Corp. has a beta of 1.930, suggesting its more volatile than the S&P 500 by 92.97%.

  • Which is a Better Dividend Stock OGI.TO or WEED.TO?

    Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Canopy Growth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Canopy Growth Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OGI.TO or WEED.TO?

    Organigram Global, Inc. quarterly revenues are $70.8M, which are larger than Canopy Growth Corp. quarterly revenues of $66.7M. Organigram Global, Inc.'s net income of -$6.3M is lower than Canopy Growth Corp.'s net income of -$1.6M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 138.95x while Canopy Growth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.44x versus 1.57x for Canopy Growth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OGI.TO
    Organigram Global, Inc.
    1.44x 138.95x $70.8M -$6.3M
    WEED.TO
    Canopy Growth Corp.
    1.57x -- $66.7M -$1.6M
  • Which has Higher Returns OGI.TO or XLY.TO?

    Auxly Cannabis Group, Inc. has a net margin of -8.89% compared to Organigram Global, Inc.'s net margin of 51.36%. Organigram Global, Inc.'s return on equity of 2.28% beat Auxly Cannabis Group, Inc.'s return on equity of 34.07%.

    Company Gross Margin Earnings Per Share Invested Capital
    OGI.TO
    Organigram Global, Inc.
    8.07% -$0.05 $394.6M
    XLY.TO
    Auxly Cannabis Group, Inc.
    22.15% $0.01 $238.5M
  • What do Analysts Say About OGI.TO or XLY.TO?

    Organigram Global, Inc. has a consensus price target of $3.00, signalling upside risk potential of 13.64%. On the other hand Auxly Cannabis Group, Inc. has an analysts' consensus of $0.2500 which suggests that it could grow by 61.29%. Given that Auxly Cannabis Group, Inc. has higher upside potential than Organigram Global, Inc., analysts believe Auxly Cannabis Group, Inc. is more attractive than Organigram Global, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    OGI.TO
    Organigram Global, Inc.
    3 1 0
    XLY.TO
    Auxly Cannabis Group, Inc.
    1 0 0
  • Is OGI.TO or XLY.TO More Risky?

    Organigram Global, Inc. has a beta of 2.213, which suggesting that the stock is 121.273% more volatile than S&P 500. In comparison Auxly Cannabis Group, Inc. has a beta of 1.254, suggesting its more volatile than the S&P 500 by 25.413%.

  • Which is a Better Dividend Stock OGI.TO or XLY.TO?

    Organigram Global, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Auxly Cannabis Group, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Organigram Global, Inc. pays -- of its earnings as a dividend. Auxly Cannabis Group, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios OGI.TO or XLY.TO?

    Organigram Global, Inc. quarterly revenues are $70.8M, which are larger than Auxly Cannabis Group, Inc. quarterly revenues of $39.9M. Organigram Global, Inc.'s net income of -$6.3M is lower than Auxly Cannabis Group, Inc.'s net income of $20.5M. Notably, Organigram Global, Inc.'s price-to-earnings ratio is 138.95x while Auxly Cannabis Group, Inc.'s PE ratio is 5.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Organigram Global, Inc. is 1.44x versus 1.55x for Auxly Cannabis Group, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    OGI.TO
    Organigram Global, Inc.
    1.44x 138.95x $70.8M -$6.3M
    XLY.TO
    Auxly Cannabis Group, Inc.
    1.55x 5.08x $39.9M $20.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Tesla Stock Go Up In 2026?
Will Tesla Stock Go Up In 2026?

EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…

What Are the Best AI Power Stocks?
What Are the Best AI Power Stocks?

As the construction of AI infrastructure accelerates, the gap between…

Is IONQ The Best Quantum Stock to Buy?
Is IONQ The Best Quantum Stock to Buy?

Riding a wave of investor enthusiasm for the technology, quantum…

Stock Ideas

Sell
47
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 60x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
73
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 39x

Alerts

Buy
80
FEIM alert for Dec 16

Frequency Electronics, Inc. [FEIM] is down 3.51% over the past day.

Buy
57
MOD alert for Dec 15

Modine Manufacturing Co. [MOD] is up 1.79% over the past day.

Sell
42
OKLO alert for Dec 15

Oklo, Inc. [OKLO] is down 5.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock